-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Downgrades Boston Scientific to Neutral, Lowers Price Target to $50

Benzinga·09/17/2026 13:30:41
语音播报
Citigroup analyst Joanne Wuensch downgrades Boston Scientific (NYSE:BSX) from Buy to Neutral and lowers the price target from $57 to $50.